| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |